🔎 Trials Near Me

Pradžia › Astma › Wisconsin

Astma klinikiniai tyrimai Wisconsin

7 tyrimai dėl Astma ieško dalyvių vietose Wisconsin.

Miestai Wisconsin

Oficialus tyrimo tekstas (anglų kalba)

A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

  • GSK Investigational Site, Milwaukee
Renkami dalyviai3 fazė
Amžius nuo 12 iki 17 · Visoms lytims · Atnaujinta 2026-09-30 · NCT05757102

Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

  • Research Site, Milwaukee
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-25 · NCT06932263

ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults

  • Enveda Investigative Site, Madison
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-24 · NCT07301255

Microglia Activation in Asthma

  • University of Wisconsin Madison, Madison
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-24 · NCT04307667

A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

  • Teva Investigational Site 12062, Greenfield
Renkami dalyviai3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-08-31 · NCT06664619

Comparison of Microglial Activation in Severe Asthma and Healthy Controls

  • Center for Healthy Minds, Madison
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-08-05 · NCT06299592

Use of fenoTRACK Device for Monitoring Changes of Fractional Exhaled Nitric Oxide (FeNO) in Uncontrolled Asthma Subjects and Controlled Asthma Subjects

  • Allergy, Asthma & Sinus Center, S.C., Greenfield
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 5 iki 100 · Visoms lytims · Atnaujinta 2026-06-02 · NCT07228026

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.